WallStSmart

UFP Technologies Inc (UFPT) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

UFP Technologies Inc stock (UFPT) is currently trading at $189.57. UFP Technologies Inc PE ratio is 21.83. UFP Technologies Inc PS ratio (Price-to-Sales) is 2.44. Analyst consensus price target for UFPT is $324.50. WallStSmart rates UFPT as Underperform.

  • UFPT PE ratio analysis and historical PE chart
  • UFPT PS ratio (Price-to-Sales) history and trend
  • UFPT intrinsic value — DCF, Graham Number, EPV models
  • UFPT stock price prediction 2025 2026 2027 2028 2029 2030
  • UFPT fair value vs current price
  • UFPT insider transactions and insider buying
  • Is UFPT undervalued or overvalued?
  • UFP Technologies Inc financial analysis — revenue, earnings, cash flow
  • UFPT Piotroski F-Score and Altman Z-Score
  • UFPT analyst price target and Smart Rating
UFPT

UFP Technologies Inc

NASDAQHEALTHCARE
$189.57
$0.81 (0.43%)
52W$178.26
$274.93
Target$324.50+71.2%

📊 No data available

Try selecting a different time range

IV

UFPT Intrinsic Value Analysis for Value Investors

Benjamin Graham Formula · UFP Technologies Inc (UFPT)

Margin of Safety
-70.3%
Significantly Overvalued
UFPT Fair Value
$154.70
Graham Formula
Current Price
$189.57
$34.87 above fair value
Undervalued
Fair: $154.70
Overvalued
Price $189.57
Graham IV $154.70
Analyst $324.50

UFPT trades 70% above its Graham fair value of $154.70, indicating the stock may be overvalued at current levels.

Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.

WallStSmart

Smart Analysis

UFP Technologies Inc (UFPT) · 10 metrics scored

Smart Score

49
out of 100
Grade: D+
Hold
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in institutional own.. Concerns around peg ratio and revenue growth. Mixed signals suggest waiting for clearer direction before acting.

UFP Technologies Inc (UFPT) Key Strengths (2)

Avg Score: 8.5/10
Institutional Own.Quality
115.90%10/10

115.90% of shares held by major funds and institutions

Return on EquityProfitability
17.80%7/10

Solid profitability: $18 profit per $100 equity

Supporting Valuation Data

EV/Revenue
2.663
Undervalued
UFPT Target Price
$324.5
37% Upside

UFP Technologies Inc (UFPT) Areas to Watch (8)

Avg Score: 4.1/10
PEG RatioValuation
3.802/10

Very expensive relative to growth, significant premium

Revenue GrowthGrowth
3.40%2/10

Revenue growing slowly at 3.40% annually

Operating MarginProfitability
14.10%4/10

Thin operating margins with cost pressures present

Price/BookValuation
3.474/10

Premium pricing at 3.5x book value

EPS GrowthGrowth
6.80%4/10

Modest earnings growth at 6.80%

Market CapQuality
$1.47B5/10

Small-cap company with higher risk but more growth potential

Price/SalesValuation
2.446/10

Revenue is fairly priced at 2.44x sales

Profit MarginProfitability
11.30%6/10

Decent profitability, keeps $11 per $100 revenue

UFP Technologies Inc (UFPT) Detailed Analysis Report

Overall Assessment

This company scores 49/100 in our Smart Analysis, earning a D+ grade. Out of 10 metrics analyzed, 2 register as strengths (avg 8.5/10) while 8 fall into concern territory (avg 4.1/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on Institutional Own., Return on Equity. Profitability is solid with Return on Equity at 17.80%.

The Bear Case

The primary concerns are PEG Ratio, Revenue Growth, Operating Margin. Some valuation metrics including PEG Ratio (3.80), Price/Sales (2.44), Price/Book (3.47) suggest expensive pricing. Growth concerns include Revenue Growth at 3.40%, EPS Growth at 6.80%, which may limit upside. Profitability pressure is visible in Operating Margin at 14.10%, Profit Margin at 11.30%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether PEG Ratio improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 17.80% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at 3.40% needing to reaccelerate.

Risk Considerations

Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Fundamental challenges outweigh strengths at current levels. PEG Ratio and Revenue Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

UFPT Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

UFPT's Price-to-Sales ratio of 2.44x trades 131% above its historical average of 1.06x (96th percentile), historically expensive. The current valuation is 11% below its historical high of 2.75x set in Mar 2026, and 919% above its historical low of 0.24x in Jan 2006.

Compare UFPT with Competitors

Top MEDICAL DEVICES stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for UFP Technologies Inc (UFPT) · HEALTHCAREMEDICAL DEVICES

The Big Picture

UFP Technologies Inc is a strong growth company balancing expansion with improving profitability. Revenue reached 603M with 340% growth year-over-year. Profit margins of 11.3% are healthy, with room for further expansion as the business scales.

Key Findings

Strong Revenue Growth

Revenue growing at 340% YoY, reaching 603M. This pace significantly outperforms most MEDICAL DEVICES peers.

Excellent Capital Efficiency

ROE of 1780.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.

What to Watch Next

Margin expansion: can UFP Technologies Inc push profit margins above 15% as the business scales?

Growth sustainability: can UFP Technologies Inc maintain 340%+ revenue growth, or will competition slow it down?

Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact UFP Technologies Inc.

Bottom Line

UFP Technologies Inc offers an attractive blend of growth (340% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions(17 last 3 months)

Total Buys
11
Total Sells
6

Data sourced from SEC Form 4 filings

Last updated: 8:25:07 AM

About UFP Technologies Inc(UFPT)

Exchange

NASDAQ

Sector

HEALTHCARE

Industry

MEDICAL DEVICES

Country

USA

UFP Technologies, Inc. designs and converts foams, films and plastic materials for the medical, automotive, consumer, electronic, industrial, aerospace and defense markets in the United States. The company is headquartered in Newburyport, Massachusetts.